Prostate Implants New Zealand Ltd logo Prostate Implants NZ Ltd provide effective treatment of prostate cancer Couple discuss brachytherapy treatment
Prostate cancer survivors enjoy their lives
Prostate Implants New Zealand specialists in brachytherapy for prostate cancer
Line of brachtherapy seeds
New Zealand specialists in brachytherapy for prostate cancer Survival rate for brachtherapy is 85% over 15 years
  Brachytherapy

Suitability

Pros & Cons

Treatment Costs

About Us

Quality Assurance

Scientific Papers

Helpful Resources

Contact Us

Disclaimer

Home

 

Permanent Brachytherapy is a most appropriate treatment option for many men with early prostate cancer. The relapse-free survival rate (~85% at 10 to15 years) is equal to the best surgical results.

In 1999 Prostate Implants New Zealand Ltd were the first group to introduce prostate brachytherapy treatment as an option for men in New Zealand. We are now a very experienced team.

Permanent brachytherapy is a high-tech procedure and right from the start we instigated a quality assurance program to assess the quality of the implants and thus the success and safety of the brachytherapy treatment. We have presented our data regularly at national and international meetings

Brachytherapy is recognised by health insurance companies who fund it in a similar way to surgical treatments. Unfortunately it is not provided in the public health system because of the higher cost.

The advantages of brachytherapy include:
  • Short hospital stay - usually overnight
  • Minimally invasive procedure (not an operation)
  • Early return to usual activities
  • Few long term side effects
Southern Cross brightside Hospital

Prostate Implants NZ Ltd uses facililties at Southern Cross Healthcare's Brightside Hospital, Epsom (shown above).